Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

E Rossi, IG Zizzari, A Di Filippo… - Human Vaccines & …, 2022 - Taylor & Francis
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …

[PDF][PDF] Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

E Rossi, IG Zizzari, A Di Filippo, A Acampora… - 2022 - researchgate.net
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

E Rossi, IG Zizzari, A Di Filippo… - Human vaccines & …, 2022 - pubmed.ncbi.nlm.nih.gov
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study.

E Rossi, IG Zizzari, A Di Filippo… - Human Vaccines & …, 2022 - europepmc.org
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

E Rossi, IG Zizzari, A Di Filippo, A Acampora… - HUMAN VACCINES & …, 2022 - iris.uniroma1.it
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

E Rossi, IG Zizzari, A Di Filippo… - HUMAN VACCINES …, 2022 - publicatt.unicatt.it
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …

[HTML][HTML] Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

E Rossi, IG Zizzari, A Di Filippo… - Human Vaccines & …, 2022 - ncbi.nlm.nih.gov
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study.

E Rossi, IG Zizzari, A Di Filippo… - Human Vaccines & …, 2022 - europepmc.org
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …

[PDF][PDF] Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

E Rossi, IG Zizzari, A Di Filippo, A Acampora… - 2022 - iris.uniroma1.it
Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is
commonly employed, despite the low activity, considering the lack of other effective systemic …